Drug and pharmaceutical recalls

Taro Pharmaceuticals is recalling one lot of fluocinonide 0.05% cream due to a manufacturing defect. Testing found the cream's thickness was thicker than specifications allow, which could affect how the medication works on your skin.

Payless Compounders is recalling a compounded semaglutide injection due to lack of assurance of sterility. The affected product is a 0.5 mL vial from lot 01-27-2026@14S.5 distributed in Oregon. No injuries have been reported so far.

The FDA inspected the manufacturing facility for QC Quality Choice menthol cough drops on August 15, 2025, and found observations that may affect product quality. The company is recalling one lot of vanilla honey flavor cough drops sold nationwide.

QC Quality Choice menthol cough drops are being recalled because the FDA found quality concerns during an inspection of the manufacturing facility on August 15, 2025. The recall affects specific lot numbers with expiration dates in May and July 2026. No injuries have been reported.

QC Quality Choice Menthol-Cough Suppressant Oral Anesthetic Cough Drops in Honey Lemon flavor are being recalled because the FDA found quality concerns during an inspection of the manufacturing facility in August 2025. The affected product is the 30-count bag with lot number 20240720 and expiration date 07/20/2026.

QC Quality Choice Pectin Oral Demulcent Throat Soothing Drops (Creamy Strawberry, 30-count) are being recalled due to manufacturing quality issues found during an FDA inspection. The recall affects lot #20240720 with an expiration date of 07/20/2026, distributed nationwide.

The FDA inspected the manufacturing facility for QC Quality Choice Menthol-Cough Suppressant Oral Anesthetic Cough Drops on August 15, 2025, and identified quality concerns. The recall affects specific lots distributed nationwide. No injuries have been reported.

The FDA inspected the manufacturing facility for QC Quality Choice menthol cough drops on August 15, 2025, and found quality concerns. The company is recalling cherry-flavored cough drops from two specific production batches out of an abundance of caution.

QC Quality Choice menthol cough drops (black cherry flavor, sugar free) are being recalled because the FDA found quality control issues during a factory inspection on August 15, 2025. The specific concern affects lot #20240720 with expiration date 07/20/2026. No injuries have been reported.

MGC Health Menthol Cough Drops (Honey Lemon flavor, 80-count bags) are being recalled because the FDA found quality concerns during an inspection of the manufacturing facility on August 15, 2025. The recall affects lot #20240730 with an expiration date of July 30, 2026, distributed nationwide.

MGC Health Menthol Cough Drops (Honey Lemon flavor, 30-count bags) are being recalled after the FDA found quality concerns during an inspection of the manufacturing facility on August 15, 2025. The recall affects products with lot number 20240524 and expiration date 05/24/2026 distributed nationwide.

The FDA recommended a recall of MGC Health Menthol Cough Drops (Sugar Free, Honey Lemon) after inspecting the manufacturing facility on August 15, 2025, and identifying quality control issues. The recall affects three specific product lots distributed nationwide.

The FDA inspected the manufacturing facility for these cough drops on August 15, 2025, and found observations that may affect product quality. The affected product is a 30-count bag of Discount Drug Mart menthol cough drops (Lot #20241030, expiring 10/30/2026) distributed nationwide.

The FDA inspected the manufacturing facility for these honey lemon menthol cough drops on August 15, 2025, and found observations that may affect product quality. The affected product is a 30-count bag with lot number 20241030 and expiration date 10/30/2026, distributed nationwide.

The FDA inspected the manufacturing facility for Caring Mill menthol cough drops on August 15, 2025, and found observations that raised concerns about product quality. The manufacturer is recalling the product out of caution. No injuries have been reported.

The FDA recommended a recall of Exchange Select menthol cough drops after inspecting the manufacturing facility in China on August 15, 2025, and finding observations that may affect product quality. The affected product is a 30-count bag with lot number 20241030 and expiration date 10/30/2026.

The FDA found quality concerns at the manufacturing facility during an inspection on August 15, 2025. Exchange Select menthol cough drops (30-count bags, lot #20241030, expiring 10/30/2026) sold at military exchanges may be affected. No injuries have been reported.

SLMD Benzoyl Peroxide Acne Lotion 2.5% in 0.7 fl. oz and 1.5 fl. oz bottles has been found to contain benzene, a chemical that should not be present in this product. This affects approximately 2,500 bottles distributed nationwide. No injuries have been reported.

Sandra Lee MD's SLMD BP Acne Spot Treatment (10% Benzoyl Peroxide) has been recalled because it contains benzene, a harmful chemical. The affected product is sold in 0.5 fl. oz bottles with lot numbers 2567200 (expires 8/1/26) or 2691600 (expires 10/30/2027). No injuries have been reported.

HydroPeptide Clear Alliance Serum (2.5% benzoyl peroxide) contains benzene, a harmful chemical not intended in the product. The affected bottles are 1 FL OZ and 2 FL OZ sizes with lot numbers 2518800 and 2518900. No injuries have been reported, but the FDA has issued a recall due to potential health risks from benzene exposure.

FarmHouse Fresh Midnight Clearing night lotion (2.5% benzoyl peroxide) contains benzene, a harmful chemical not meant to be in this product. The contamination was found in three specific lot numbers. No injuries have been reported so far.

Cipla USA is recalling certain batches of cinacalcet 90 mg tablets because they contain higher-than-safe levels of a chemical impurity called N-Nitroso Cinacalcet. The affected bottles were distributed nationwide. No injuries have been reported.

Cipla USA is recalling specific lots of Cinacalcet Hydrochloride 60 mg tablets because they contain higher-than-acceptable levels of N-Nitroso Cinacalcet, a nitrosamine impurity. This impurity can pose a health risk with long-term exposure. The affected lots were distributed nationwide.

Cipla USA is recalling specific lots of Cinacalcet Hydrochloride 30 mg tablets because they contain higher-than-acceptable levels of a chemical impurity called N-Nitroso Cinacalcet. The affected tablets were distributed nationwide. This is a manufacturing quality issue; no injuries have been reported.

Teva Pharmaceuticals is recalling specific batches of Clonidine Transdermal System patches (0.3 mg/day) because they were manufactured using an unapproved raw material that does not meet quality standards. The affected patches were distributed in the U.S. No injuries have been reported.

Teva Pharmaceuticals is recalling specific lots of Clonidine Transdermal System (0.2 mg/day) patches because they were made with an unapproved raw material that does not meet manufacturing standards. Two lots are affected: 100060002 (expires 07/2026) and 100066802 (expires 05/2027). No injuries have been reported.

Teva Pharmaceuticals is recalling certain Clonidine Transdermal System patches (0.1 mg/day) because they were manufactured using an unapproved raw material that does not meet FDA standards. The affected patches were distributed in the U.S. The company and FDA are working to ensure the product is removed from use.

GE Healthcare discovered particles in certain vials of Omnipaque (iohexol), a contrast dye used during medical imaging procedures. The contamination affects 11 specific lot numbers distributed nationwide. No injuries have been reported so far.

GE Healthcare has recalled specific lots of Omnipaque (iohexol) injection, a contrast dye used in medical imaging, because some vials may contain visible particles. This could affect the safety of the procedure if the contaminated solution is used.

Teva Pharmaceuticals is recalling certain batches of Isotretinoin 40 mg capsules because some capsules may be too strong (superpotent) or too weak (subpotent). This medication is a prescription acne treatment that requires precise dosing. The affected batches were distributed in Florida, Ohio, Puerto Rico, and Mississippi.